Report Detail
Global Therapeutic Antibody Discovery Platform Market Growth (Status and Outlook) 2023-2029
- RnM4502127 |
- 13 January, 2023 |
- Global |
- 114 Pages |
- LPI(LP Information) |
- Medical Industry
Antibody discovery platforms have emerged in recent years as an important source of both therapeutic molecules and research reagents.
Newest research report, the “Therapeutic Antibody Discovery Platform Industry Forecast” looks at past sales and reviews total world Therapeutic Antibody Discovery Platform sales in 2022, providing a comprehensive analysis by region and market sector of projected Therapeutic Antibody Discovery Platform sales for 2023 through 2029. With Therapeutic Antibody Discovery Platform sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Therapeutic Antibody Discovery Platform industry.
This Insight Report provides a comprehensive analysis of the global Therapeutic Antibody Discovery Platform landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Therapeutic Antibody Discovery Platform portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Therapeutic Antibody Discovery Platform market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Therapeutic Antibody Discovery Platform and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Therapeutic Antibody Discovery Platform.
The global Therapeutic Antibody Discovery Platform market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Therapeutic Antibody Discovery Platform is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Therapeutic Antibody Discovery Platform is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Therapeutic Antibody Discovery Platform is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Therapeutic Antibody Discovery Platform players cover Abveris, YUMAB, Ablexis, AvantGen, OXGENE, Evotec, Alacrita, Invetx and Charles River Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Therapeutic Antibody Discovery Platform market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Animal
Human
Segmentation by application
Pharmaceutical and Biotechnology Companies
Research Laboratories
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abveris
YUMAB
Ablexis
AvantGen
OXGENE
Evotec
Alacrita
Invetx
Charles River Laboratories
Aerium Therapeutics
Chugai Pharmaceutical
AbCellera
Twist Bioscience
Talem Therapeutics
Bio-Rad
Memo Therapeutics
OmniAb
Antibody Solutions
Lepu Biopharma
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Therapeutic Antibody Discovery Platform Market Size 2018-2029
- 2.1.2 Therapeutic Antibody Discovery Platform Market Size CAGR by Region 2018 VS 2022 VS 2029
- 2.2 Therapeutic Antibody Discovery Platform Segment by Type
- 2.2.1 Animal
- 2.2.2 Human
- 2.3 Therapeutic Antibody Discovery Platform Market Size by Type
- 2.3.1 Therapeutic Antibody Discovery Platform Market Size CAGR by Type (2018 VS 2022 VS 2029)
- 2.3.2 Global Therapeutic Antibody Discovery Platform Market Size Market Share by Type (2018-2023)
- 2.4 Therapeutic Antibody Discovery Platform Segment by Application
- 2.4.1 Pharmaceutical and Biotechnology Companies
- 2.4.2 Research Laboratories
- 2.5 Therapeutic Antibody Discovery Platform Market Size by Application
- 2.5.1 Therapeutic Antibody Discovery Platform Market Size CAGR by Application (2018 VS 2022 VS 2029)
- 2.5.2 Global Therapeutic Antibody Discovery Platform Market Size Market Share by Application (2018-2023)
3 Therapeutic Antibody Discovery Platform Market Size by Player
- 3.1 Therapeutic Antibody Discovery Platform Market Size Market Share by Players
- 3.1.1 Global Therapeutic Antibody Discovery Platform Revenue by Players (2018-2023)
- 3.1.2 Global Therapeutic Antibody Discovery Platform Revenue Market Share by Players (2018-2023)
- 3.2 Global Therapeutic Antibody Discovery Platform Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Therapeutic Antibody Discovery Platform by Regions
- 4.1 Therapeutic Antibody Discovery Platform Market Size by Regions (2018-2023)
- 4.2 Americas Therapeutic Antibody Discovery Platform Market Size Growth (2018-2023)
- 4.3 APAC Therapeutic Antibody Discovery Platform Market Size Growth (2018-2023)
- 4.4 Europe Therapeutic Antibody Discovery Platform Market Size Growth (2018-2023)
- 4.5 Middle East & Africa Therapeutic Antibody Discovery Platform Market Size Growth (2018-2023)
5 Americas
- 5.1 Americas Therapeutic Antibody Discovery Platform Market Size by Country (2018-2023)
- 5.2 Americas Therapeutic Antibody Discovery Platform Market Size by Type (2018-2023)
- 5.3 Americas Therapeutic Antibody Discovery Platform Market Size by Application (2018-2023)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Therapeutic Antibody Discovery Platform Market Size by Region (2018-2023)
- 6.2 APAC Therapeutic Antibody Discovery Platform Market Size by Type (2018-2023)
- 6.3 APAC Therapeutic Antibody Discovery Platform Market Size by Application (2018-2023)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Therapeutic Antibody Discovery Platform by Country (2018-2023)
- 7.2 Europe Therapeutic Antibody Discovery Platform Market Size by Type (2018-2023)
- 7.3 Europe Therapeutic Antibody Discovery Platform Market Size by Application (2018-2023)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Therapeutic Antibody Discovery Platform by Region (2018-2023)
- 8.2 Middle East & Africa Therapeutic Antibody Discovery Platform Market Size by Type (2018-2023)
- 8.3 Middle East & Africa Therapeutic Antibody Discovery Platform Market Size by Application (2018-2023)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Therapeutic Antibody Discovery Platform Market Forecast
- 10.1 Global Therapeutic Antibody Discovery Platform Forecast by Regions (2024-2029)
- 10.1.1 Global Therapeutic Antibody Discovery Platform Forecast by Regions (2024-2029)
- 10.1.2 Americas Therapeutic Antibody Discovery Platform Forecast
- 10.1.3 APAC Therapeutic Antibody Discovery Platform Forecast
- 10.1.4 Europe Therapeutic Antibody Discovery Platform Forecast
- 10.1.5 Middle East & Africa Therapeutic Antibody Discovery Platform Forecast
- 10.2 Americas Therapeutic Antibody Discovery Platform Forecast by Country (2024-2029)
- 10.2.1 United States Therapeutic Antibody Discovery Platform Market Forecast
- 10.2.2 Canada Therapeutic Antibody Discovery Platform Market Forecast
- 10.2.3 Mexico Therapeutic Antibody Discovery Platform Market Forecast
- 10.2.4 Brazil Therapeutic Antibody Discovery Platform Market Forecast
- 10.3 APAC Therapeutic Antibody Discovery Platform Forecast by Region (2024-2029)
- 10.3.1 China Therapeutic Antibody Discovery Platform Market Forecast
- 10.3.2 Japan Therapeutic Antibody Discovery Platform Market Forecast
- 10.3.3 Korea Therapeutic Antibody Discovery Platform Market Forecast
- 10.3.4 Southeast Asia Therapeutic Antibody Discovery Platform Market Forecast
- 10.3.5 India Therapeutic Antibody Discovery Platform Market Forecast
- 10.3.6 Australia Therapeutic Antibody Discovery Platform Market Forecast
- 10.4 Europe Therapeutic Antibody Discovery Platform Forecast by Country (2024-2029)
- 10.4.1 Germany Therapeutic Antibody Discovery Platform Market Forecast
- 10.4.2 France Therapeutic Antibody Discovery Platform Market Forecast
- 10.4.3 UK Therapeutic Antibody Discovery Platform Market Forecast
- 10.4.4 Italy Therapeutic Antibody Discovery Platform Market Forecast
- 10.4.5 Russia Therapeutic Antibody Discovery Platform Market Forecast
- 10.5 Middle East & Africa Therapeutic Antibody Discovery Platform Forecast by Region (2024-2029)
- 10.5.1 Egypt Therapeutic Antibody Discovery Platform Market Forecast
- 10.5.2 South Africa Therapeutic Antibody Discovery Platform Market Forecast
- 10.5.3 Israel Therapeutic Antibody Discovery Platform Market Forecast
- 10.5.4 Turkey Therapeutic Antibody Discovery Platform Market Forecast
- 10.5.5 GCC Countries Therapeutic Antibody Discovery Platform Market Forecast
- 10.6 Global Therapeutic Antibody Discovery Platform Forecast by Type (2024-2029)
- 10.7 Global Therapeutic Antibody Discovery Platform Forecast by Application (2024-2029)
11 Key Players Analysis
- 11.1 Abveris
- 11.1.1 Abveris Company Information
- 11.1.2 Abveris Therapeutic Antibody Discovery Platform Product Offered
- 11.1.3 Abveris Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
- 11.1.4 Abveris Main Business Overview
- 11.1.5 Abveris Latest Developments
- 11.2 YUMAB
- 11.2.1 YUMAB Company Information
- 11.2.2 YUMAB Therapeutic Antibody Discovery Platform Product Offered
- 11.2.3 YUMAB Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
- 11.2.4 YUMAB Main Business Overview
- 11.2.5 YUMAB Latest Developments
- 11.3 Ablexis
- 11.3.1 Ablexis Company Information
- 11.3.2 Ablexis Therapeutic Antibody Discovery Platform Product Offered
- 11.3.3 Ablexis Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
- 11.3.4 Ablexis Main Business Overview
- 11.3.5 Ablexis Latest Developments
- 11.4 AvantGen
- 11.4.1 AvantGen Company Information
- 11.4.2 AvantGen Therapeutic Antibody Discovery Platform Product Offered
- 11.4.3 AvantGen Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
- 11.4.4 AvantGen Main Business Overview
- 11.4.5 AvantGen Latest Developments
- 11.5 OXGENE
- 11.5.1 OXGENE Company Information
- 11.5.2 OXGENE Therapeutic Antibody Discovery Platform Product Offered
- 11.5.3 OXGENE Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
- 11.5.4 OXGENE Main Business Overview
- 11.5.5 OXGENE Latest Developments
- 11.6 Evotec
- 11.6.1 Evotec Company Information
- 11.6.2 Evotec Therapeutic Antibody Discovery Platform Product Offered
- 11.6.3 Evotec Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
- 11.6.4 Evotec Main Business Overview
- 11.6.5 Evotec Latest Developments
- 11.7 Alacrita
- 11.7.1 Alacrita Company Information
- 11.7.2 Alacrita Therapeutic Antibody Discovery Platform Product Offered
- 11.7.3 Alacrita Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
- 11.7.4 Alacrita Main Business Overview
- 11.7.5 Alacrita Latest Developments
- 11.8 Invetx
- 11.8.1 Invetx Company Information
- 11.8.2 Invetx Therapeutic Antibody Discovery Platform Product Offered
- 11.8.3 Invetx Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
- 11.8.4 Invetx Main Business Overview
- 11.8.5 Invetx Latest Developments
- 11.9 Charles River Laboratories
- 11.9.1 Charles River Laboratories Company Information
- 11.9.2 Charles River Laboratories Therapeutic Antibody Discovery Platform Product Offered
- 11.9.3 Charles River Laboratories Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
- 11.9.4 Charles River Laboratories Main Business Overview
- 11.9.5 Charles River Laboratories Latest Developments
- 11.10 Aerium Therapeutics
- 11.10.1 Aerium Therapeutics Company Information
- 11.10.2 Aerium Therapeutics Therapeutic Antibody Discovery Platform Product Offered
- 11.10.3 Aerium Therapeutics Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
- 11.10.4 Aerium Therapeutics Main Business Overview
- 11.10.5 Aerium Therapeutics Latest Developments
- 11.11 Chugai Pharmaceutical
- 11.11.1 Chugai Pharmaceutical Company Information
- 11.11.2 Chugai Pharmaceutical Therapeutic Antibody Discovery Platform Product Offered
- 11.11.3 Chugai Pharmaceutical Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
- 11.11.4 Chugai Pharmaceutical Main Business Overview
- 11.11.5 Chugai Pharmaceutical Latest Developments
- 11.12 AbCellera
- 11.12.1 AbCellera Company Information
- 11.12.2 AbCellera Therapeutic Antibody Discovery Platform Product Offered
- 11.12.3 AbCellera Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
- 11.12.4 AbCellera Main Business Overview
- 11.12.5 AbCellera Latest Developments
- 11.13 Twist Bioscience
- 11.13.1 Twist Bioscience Company Information
- 11.13.2 Twist Bioscience Therapeutic Antibody Discovery Platform Product Offered
- 11.13.3 Twist Bioscience Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
- 11.13.4 Twist Bioscience Main Business Overview
- 11.13.5 Twist Bioscience Latest Developments
- 11.14 Talem Therapeutics
- 11.14.1 Talem Therapeutics Company Information
- 11.14.2 Talem Therapeutics Therapeutic Antibody Discovery Platform Product Offered
- 11.14.3 Talem Therapeutics Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
- 11.14.4 Talem Therapeutics Main Business Overview
- 11.14.5 Talem Therapeutics Latest Developments
- 11.15 Bio-Rad
- 11.15.1 Bio-Rad Company Information
- 11.15.2 Bio-Rad Therapeutic Antibody Discovery Platform Product Offered
- 11.15.3 Bio-Rad Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
- 11.15.4 Bio-Rad Main Business Overview
- 11.15.5 Bio-Rad Latest Developments
- 11.16 Memo Therapeutics
- 11.16.1 Memo Therapeutics Company Information
- 11.16.2 Memo Therapeutics Therapeutic Antibody Discovery Platform Product Offered
- 11.16.3 Memo Therapeutics Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
- 11.16.4 Memo Therapeutics Main Business Overview
- 11.16.5 Memo Therapeutics Latest Developments
- 11.17 OmniAb
- 11.17.1 OmniAb Company Information
- 11.17.2 OmniAb Therapeutic Antibody Discovery Platform Product Offered
- 11.17.3 OmniAb Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
- 11.17.4 OmniAb Main Business Overview
- 11.17.5 OmniAb Latest Developments
- 11.18 Antibody Solutions
- 11.18.1 Antibody Solutions Company Information
- 11.18.2 Antibody Solutions Therapeutic Antibody Discovery Platform Product Offered
- 11.18.3 Antibody Solutions Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
- 11.18.4 Antibody Solutions Main Business Overview
- 11.18.5 Antibody Solutions Latest Developments
- 11.19 Lepu Biopharma
- 11.19.1 Lepu Biopharma Company Information
- 11.19.2 Lepu Biopharma Therapeutic Antibody Discovery Platform Product Offered
- 11.19.3 Lepu Biopharma Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
- 11.19.4 Lepu Biopharma Main Business Overview
- 11.19.5 Lepu Biopharma Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Therapeutic Antibody Discovery Platform. Industry analysis & Market Report on Therapeutic Antibody Discovery Platform is a syndicated market report, published as Global Therapeutic Antibody Discovery Platform Market Growth (Status and Outlook) 2023-2029. It is complete Research Study and Industry Analysis of Therapeutic Antibody Discovery Platform market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
